Revvity Gene Delivery competitive analysis

Loading summary...

Explore Revvity Gene Delivery's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 22, 2021Retroviral Transduction Using Poloxamers1
Oct 28, 2020Retroviral Transduction Using Poloxamers1

Latest publications and patents of Revvity Gene Delivery New

Explore the latest publications and patents granted to Revvity Gene Delivery, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Revvity Gene Delivery

Dec 22, 2021Retroviral Transduction Using PoloxamersOpposition Rejected
Oct 28, 2020Retroviral Transduction Using PoloxamersOpposition Rejected

Latest PTAB cases involving Revvity Gene Delivery

Discover the latest PTAB cases involving Revvity Gene Delivery, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Revvity Gene Delivery with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
REVVITY GENE DELIVERY - 2 - -
KONIG SZYNKA TILMANN VON RENESSE34 - - -